DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tarextumab
Tarextumab
Precision Medicine for Human Cancers with Notch Signaling Dysregulation (Review)
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
2017 Immuno-Oncology Medicines in Development
The Two Tontti Tudiul Lui Hi Ha Unit
Gastrointestinal Cancer Tumor Panel
High Delta-Like Ligand 4 Expression Correlates with a Poor Clinical
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
ABOUT the TEST: PATIENT RESULTS TUMOR TYPE: BREAST CARCINOMA (NOS) Genomic Alterations Identified† Additional Findings† THER
2016 Medicines in Development for Rare Diseases a LIST of ORPHAN DRUGS in the PIPELINE
Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research
Adis R&D Insight
Stembook 2018.Pdf
Management of Metastatic Pancreatic Adenocarcinoma
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
(INN) for Biological and Biotechnological Substances
Company Update January 14, 2016 Safe Harbor
A61K9/51 (2006.01) — with International Search Report (Art
Orphan Drug Designation List
Top View
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Pharmaceutical Substances (INN)
Emerging Therapeutic Agents for Lung Cancer Bhagirathbhai Dholaria, William Hammond, Amanda Shreders and Yanyan Lou*
Presentation Title
Advances in Antibody Therapeutics Targeting Small-Cell Lung Cancer
Biosimilar Product Differences Will Affect US Uptake, Amgen Predicts
Separate Financial Statements of Morphosys AG As of December 31, 2016 (German GAAP)
Anetumab Ravtansine
EP Vantage's 2016 Asco Backgrounder
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Targeting Oncoimmune Drivers of Cancer Metastasis
Non-Small Cell Lung Cancer
Oncology Drugs in the Pipeline
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Top Notch Targeting Strategies in Cancer: a Detailed Overview of Recent Insights and Current Perspectives
Tumor-Targeted Drug Conjugates As an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
Memorial Sloan Kettering ASCO Meeting Abstracts 2016
(INN) for Biological and Biotechnological Substances
WO 2015/038818 A2 19 March 2015 (19.03.2015) P O P C T
(12) United States Patent (10) Patent No.: US 9.228,020 B2 Gurney Et Al
Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016